Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. SPCX
2. USO
3. CRNX
4. VRTX
5. SPY
6. RIVN
7. NVDA
8. LMT
9. WMT
10. CMPS

Go back to Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
(NASDAQ: QNRX) Delayed: 4.80 --0 (-0%)
Previous Close $4.80    52 Week High $ 
Open $4.80    52 Week Low $ 
Day High $4.80    P/E N/A 
Day Low $4.80    EPS $ 
Volume 431